HCCA Compliance Program Task Force Headed By TAP Exec
A Health Care Compliance Association task force to develop measurements to evaluate the effectiveness of corporate compliance programs will be chaired by TAP Pharmaceuticals Ethics and Compliance Officer Stephan Vincze
You may also be interested in...
TAP Pharmaceuticals' corporate integrity agreement with the HHS Inspector General calls for annual audits of the sales and marketing documents related to transactions with the largest volume purchasers of Lupron and Prevacid.
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials